Suppr超能文献

通过Ubc9协同激活而非SUMO化作用调节PLAGL2反式激活活性。

Modulation of PLAGL2 transactivation activity by Ubc9 co-activation not SUMOylation.

作者信息

Guo Yuhong, Yang Meng-Chun W, Weissler Jonathan C, Yang Yih-Sheng

机构信息

Department of Internal Medicine, Pulmonary and Critical Care Medicine, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8558, USA.

出版信息

Biochem Biophys Res Commun. 2008 Sep 26;374(3):570-5. doi: 10.1016/j.bbrc.2008.07.064. Epub 2008 Jul 23.

Abstract

Pleomorphic adenoma gene like-2 (PLAGL2), a developmentally regulated and stress inducible zinc finger protein can be post-translationally modified by small ubiquitin-like modifier peptide (SUMO-1); and SUMOylation attenuates PLAGL2 activity on the interactive promoter. Since PLAGL2 was a transactivator of the surfactant protein-C (SP-C) promoter, we hypothesized that SUMOylation down-regulated PLAGL2-activated SP-C promoter activity. Unexpectedly, the SUMO-conjugating enzyme Ubc9 enhanced, rather than reduced, PLAGL2 activated promoter activity but did not affect TTF-1 activation of the promoter. Ubc9 mutant (Ubc9-C93S) defective in SUMO-conjugating activity also enhanced PLAGL2-driven promoter activity suggesting that the stimulatory effect of Ubc9 on SP-C promoter activation was independent of its enzymatic function. PLAGL2 mutants without the K250 and/or K269 SUMOylation sites did not further improve PLAGL2 programmed transcription nor did they abolish Ubc9 enhanced promoter activity supporting the SUMOylation-independent mechanism. Chromatin immunoprecipitation (ChIP) assay demonstrated the association of PLAGL2 and Ubc9 with the SP-C promoter in vivo. Taken together, our data suggests that Ubc9 can function as a co-factor of PLAGL2, uncoupling from its enzymatic activity, to mediate PLAGL2 interactive SP-C promoter activity.

摘要

多形性腺瘤样基因-2(PLAGL2)是一种受发育调控且可被应激诱导的锌指蛋白,可通过小泛素样修饰肽(SUMO-1)进行翻译后修饰;SUMO化作用会减弱PLAGL2在相互作用启动子上的活性。由于PLAGL2是表面活性蛋白C(SP-C)启动子的反式激活因子,我们推测SUMO化作用下调了PLAGL2激活的SP-C启动子活性。出乎意料的是,SUMO结合酶Ubc9增强而非降低了PLAGL2激活的启动子活性,但不影响该启动子的TTF-1激活。SUMO结合活性有缺陷的Ubc9突变体(Ubc9-C93S)也增强了PLAGL2驱动的启动子活性,这表明Ubc9对SP-C启动子激活的刺激作用与其酶功能无关。没有K250和/或K269 SUMO化位点的PLAGL2突变体既没有进一步改善PLAGL2编程转录,也没有消除Ubc9增强的启动子活性,这支持了不依赖SUMO化的机制。染色质免疫沉淀(ChIP)分析证明了PLAGL2和Ubc9在体内与SP-C启动子的结合。综上所述,我们的数据表明,Ubc9可以作为PLAGL2的辅因子,与其酶活性解偶联,以介导PLAGL2相互作用的SP-C启动子活性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验